Healthcare

Ownership in Dutch healthcare is constrained in ways that apply in few other sectors. Whether a provider may distribute profit at all depends on the category of care it delivers, an admission regime governs which entity is permitted to deliver that care, and a sector-specific concentration notification catches transactions that fall well below ordinary merger control thresholds. Questions that in other sectors are settled after the term sheet, such as which entity acquires what and how the group is arranged, are therefore regulatory questions in this sector from the first conversation. We advise investors, family offices, care providers, clinic and practice groups and management teams on Dutch transactions in the sector. Members of our team have, at previous firms, advised on the structuring of healthcare buy-and-build platforms and the acquisitions carried out under them.

Pencil illustration of a quiet care facility corridor with handrails and a bench.

When clients call us

  • You are acquiring a Dutch clinic, practice or care provider and need to know which approvals condition the transaction
  • A buy-and-build platform is adding practices and each acquisition raises its own admission and notification questions
  • You are selling a practice and the buyer has raised the Wtza position in due diligence
  • A care provider's governance or internal supervision needs to be brought into line with the applicable requirements
  • A structure has to accommodate the rules on profit distribution by care providers and the arrangements between group entities

Key legal & commercial issues

I.

Admission, notification and the entity that delivers the care

The Wet toetreding zorgaanbieders governs entry to the Dutch care market. A care provider subject to the notification requirement notifies before it starts to provide care. Providers that meet the statutory criteria also require an admission licence before providing care; this includes providers of medical specialist care and, subject to exceptions, providers of care under the Zorgverzekeringswet or the Wet langdurige zorg. Depending on the nature and scale of the care, requirements for independent internal supervision and annual public accountability also apply.

The transactional consequence is that the regime attaches to the care provider, in practice usually a legal entity, rather than to the business as such. In a share deal the entity that holds the admission licence and made the notification is the entity being acquired, so the position continues, although applicable changes must be notified and the licence conditions continue to apply under new ownership. In an asset deal, in a carve-out, or wherever a new entity is inserted to hold the activity, that entity is a new entrant and needs its own notification and, where the criteria are met, its own admission licence before care is provided. Legal mergers, demergers and group reorganisations raise the same question, and we establish the position for every entity in the structure at the outset rather than at closing.

II.

The NZa concentration test

The Wet marktordening gezondheidszorg, the WMG, gives the Nederlandse Zorgautoriteit a role that has no parallel in most sectors. Alongside its regulation of tariffs and performance descriptions, its transparency requirements and its supervision of the care markets, the NZa operates a sector-specific concentration review: a concentration involving a care provider that ordinarily has fifty or more persons providing care requires the approval of the NZa before it is implemented, irrespective of turnover. The assessment is largely procedural, addressing whether staff, client councils and other stakeholders have been involved, what the concentration means for the provision of care, and whether the continuity of essential care is secured.

That approval requirement sits alongside ordinary merger control. The general turnover thresholds of the Mededingingswet apply to care providers, so a transaction can require NZa approval while remaining outside merger control altogether. This test is regularly overlooked in practice, particularly on smaller practice acquisitions where the parties assume that no approval is needed. Establishing whether it is triggered belongs in the first week, because it determines the signing to closing period rather than the documentation.

III.

Practitioners, quality and governance

The Wet BIG registers individual practitioners, protects professional titles, reserves certain procedures to registered practitioners and subjects them to disciplinary law. A registration attaches to the person and not to the practice, so no transaction transfers it. Where the value of a target depends on a small number of practitioners, as it usually does in clinics and single-site practices, the retention, roll-over and restraint arrangements carry more weight than the warranty package. The engagement model is equally material, since practices commonly work with both employed and self-employed practitioners and the rules on the qualification of self-employed engagements are enforced.

Quality and governance obligations run in parallel. The Wet kwaliteit, klachten en geschillen zorg imposes, among other things, a duty to provide good care, a complaints and disputes scheme and the reporting of calamities to the Inspectie Gezondheidszorg en Jeugd. The Governance Code Zorg binds providers affiliated with the sector organisations and sets out expectations on matters including internal supervision, conflicts of interest and stakeholder involvement. The Wet medezeggenschap cliënten zorginstellingen gives client councils rights in relation to a merger or a change in control, and works council consultation under the WOR applies in the usual way. Both processes tend to determine the timetable, and both feature in the NZa's assessment.

IV.

Healthcare specifics

  • Profit distribution in healthcare is category-dependent. The applicable rules can affect which activities sit in which entity and how management, service, property and financing arrangements within a group are structured. Those arrangements should be assessed alongside the provider's care activities and funding position.
  • Ownership of care providers by private equity and other institutional investors receives sustained parliamentary and ministerial attention, particularly in general practice and dental care. We build the possibility of regulatory change into the structure and risk allocation rather than assuming that the framework will remain unchanged throughout the investment.
  • Patient data is special category data under the GDPR and is also covered by medical professional confidentiality, so due diligence proceeds on aggregated or anonymised material. The medical treatment agreement rules in the Dutch Civil Code, including the retention of records, mean that a share deal leaves the treatment agreements and the records with the same legal entity. In an asset deal, the transfer of the practice and the associated records requires a carefully sequenced approach to professional confidentiality, privacy and patient communication.
  • Premises are frequently a material part of the transaction. Clinics, practices and care homes are commonly leased rather than owned, and such premises generally fall under the lease regime for other business premises rather than the retail regime, with correspondingly limited protection against eviction. Change-of-control and consent provisions in leases, the separation of care and accommodation in long-term care, and the position of any specialised healthcare property investor as landlord are established in diligence.
  • The buy-and-build model is common in Dutch dental, ophthalmology, physiotherapy and elderly care, and veterinary practices are frequently pursued on a comparable thesis, although they sit outside the healthcare statutory regimes and are regulated under animal health legislation and veterinary disciplinary law.
  • Share transfers in BVs require a notarial deed (art. 2:196 DCC), and employees within a transferring undertaking pass to the buyer by operation of law under the transfer of undertaking rules, which is a live point where a practice is acquired as a business rather than as a company.

What we advise on

What we advise on

  • Acquisitions and disposals of clinics, practices, care providers and healthcare groups
  • Buy-and-build platforms, including the platform structure and the acquisitions carried out under it
  • Wtza admission and notification analysis across each entity in a transaction structure
  • Concentration notifications to the NZa and merger filings with the ACM
  • Legal due diligence covering admission, quality, practitioner engagement, patient data and property
  • Governance for care providers, including internal supervision and the Governance Code Zorg
  • Practitioner arrangements, participation structures and retention and restraint provisions
  • Joint ventures and cooperation arrangements between providers, and carve-outs of care activities

Typical documents and deliverables

Typical documents and deliverables

  • Share and asset purchase agreements with healthcare-specific conditions precedent
  • Platform documentation for a buy-and-build, including a repeatable acquisition template
  • Concentration notification files for the NZa and merger filings for the ACM
  • Legal due diligence reports structured around admission, quality, people, data and property
  • Shareholders' agreements and participation documentation for practitioner shareholders
  • Articles of association, internal supervision arrangements and governance regulations
  • Practitioner service, employment and self-employed engagement agreements
  • Notarial deeds, closing agendas and post-closing notification and registration deliverables

How we support the process

How we support the process

  1. 1

    An early assessment of which approvals, notifications and consultations condition the transaction, and what each of them takes

  2. 2

    Due diligence built around admission, quality, practitioner engagement, patient data and property

  3. 3

    The NZa concentration notification prepared alongside the competition analysis rather than after it

  4. 4

    Transaction documents that reflect the profit distribution and governance position of each entity in the structure

  5. 5

    Closing, notifications and the governance and registration steps that follow

Questions clients ask before instructing us

Questions clients ask before instructing us

Does an acquisition of a care provider need the approval of the NZa?
In a great many cases it does, including transactions that are small by ordinary merger control standards. The WMG requires a concentration involving a care provider that ordinarily has fifty or more persons providing care to be approved by the Nederlandse Zorgautoriteit before it is implemented, irrespective of turnover. The review is largely procedural, addressing stakeholder involvement, the effect on the provision of care and the continuity of essential care. It runs alongside merger control at the ACM, where the general turnover thresholds apply. This test is regularly overlooked in practice, particularly on smaller practice acquisitions, and it belongs in the analysis before the timetable is agreed rather than after. Where required, we coordinate the healthcare and competition analysis with specialist counsel.
Can a care provider distribute profit to its shareholders?
The answer depends on the category of care provided. The applicable framework shapes the structure: which activities sit in which entity, how the group is financed, and how management, service and property arrangements between group companies are documented. Those arrangements should be assessed together with the provider's care activities and funding position, and the structure should allow for regulatory change during the investment. We coordinate the healthcare-regulatory assessment with specialist counsel before the structure is settled.
What happens to the Wtza position when a care provider changes hands?
That depends on the structure. In a share deal the licence holder does not change, because the entity that holds the admission and made the notification is the entity being acquired, although changes to the entity and to its internal supervision are notified and the licence conditions continue to apply to the business under new ownership. In an asset deal, or wherever a newly incorporated entity will hold the activity, that entity is a new entrant under the Wet toetreding zorgaanbieders and requires its own notification and, where the statutory criteria are met, its own admission licence before care is provided. Legal mergers, demergers and internal reorganisations raise the same question, so we establish the position for each entity at the structuring stage.
What makes a healthcare buy-and-build different from other platforms?
The regulatory work repeats on every acquisition. Dutch dental, ophthalmology, physiotherapy and elderly care platforms are assembled from small practices, and each acquisition carries its own admission and notification position, its own assessment of whether an NZa concentration notification is required, and its own analysis of how the practitioners are engaged. Value depends on retaining those practitioners, since a Wet BIG registration attaches to the individual rather than to the practice, which puts weight on the retention, roll-over and restraint arrangements rather than on the warranty package. We develop the structure and a reusable document set at platform level, with the aim of using an agreed template for subsequent acquisitions and identifying recurring conditions before the seller is approached.
How do client council and works council rights affect the timetable?
They frequently determine it. The Wmcz 2018 requires a care provider to give its client council the opportunity to advise on decisions such as a transfer of control, a merger and the entry into or termination of a lasting collaboration, and the WOR gives the works council a comparable advisory right, in each case at a point at which the advice can still influence the outcome. Where the decision departs from the works council's advice, implementation is suspended for one month, during which the council can appeal to the Enterprise Chamber. The NZa also examines whether both bodies were involved, so both consultations are sequenced into the timetable before signing rather than treated as a formality afterwards.
How are patient records dealt with in a transaction?
They are not dealt with through the data room. Patient data is special category data under the GDPR and is covered by medical professional confidentiality, so due diligence proceeds on aggregated or anonymised information, and any review of individual files is exceptional and requires its own legal basis, such as patient consent. On transfer the structure decides the mechanics. In a share deal the treatment agreements and the associated records remain with the same legal entity. An asset deal moves the practice to a different provider, which requires patients to be informed about the transfer of their records, with a careful approach to their consent, and that process is planned into the timetable.

Does the transaction need NZa approval?

Get in touch